newsfilter
← Latest News
GlobeNewswire·

Bioasis Provides Update on Business Operations

NEW HAVEN, Conn., March 23, 2023 (GLOBE NEWSWIRE) -- BIOASIS TECHNOLOGIES INC. (OTCQB:BIOAF, TSX.V:BTI)) (the "Company" or "Bioasis"), a multi-asset rare and orphan disease biopharmaceutical company developing clinical